Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia

Treatment of chronic myeloid leukemia with BCR-ABL tyrosine kinase inhibitors requires full adherence in order to maximize the likelihood of achieving optimal responses, and to minimize healthcare costs. In this article, we review some of the methods available for assessing compliance, the main cons...

Description complète

Détails bibliographiques

Auteurs principaux:	Maria Helena de Almeida, Laura Fogliatto, Dulce Couto
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2014-01-01
Collection:	Revista Brasileira de Hematologia e Hemoterapia
Sujets:	Patient compliance Therapeutics Leukemia, chronic myeloid BCR-ABL positive
Accès en ligne:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842014000100054&lng=en&tlng=en
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!